约克郡肺癌筛查试验中的放射学质量保证流程及基线低剂量CT筛查肺癌的结果
该研究描述了约克郡肺癌筛查试验中低剂量CT筛查的放射学质量保证流程:对阴性扫描随机抽取5%及后续诊断肺外癌或间期肺癌的病例进行盲法复审,将原始报告评为「满意」「满意但有学习点」或「不满意」。
要点
- 阴性低剂量CT扫描采用计算机辅助检测软件后单读,质量保证复审随机抽取5%阴性扫描及所有后续诊断肺外癌或间期肺癌病例。
- 复审采用盲法,放射科医生不知复审原因,报告评为「满意」「满意但有学习点」或「不满意」。
- 6650例筛查参与者中仅2/208(1%)随机阴性扫描和1/10间期肺癌扫描最终评为「不满意」。
核心结论
- 所述流程试图在筛查扫描的回顾性复审中减少偏倚,可能为未来国家筛查项目的质量保证提供框架。
研究设计与样本
- 约克郡肺癌筛查试验中的结构化放射学质量保证流程,纳入6650例接受低剂量CT筛查的参与者,复审208例阴性扫描、11例后续肺外癌病例和10例间期肺癌病例,采用盲法复审并将原始报告评为「满意」「满意但有学习点」或「不满意」。
诊断标准与关键数值
- 原始放射学报告评分分为「满意」「满意但有学习点」和「不满意」三类。
- 随机选择的阴性扫描中「不满意」报告为2/208(1%)。
- 间期肺癌扫描中「不满意」报告为1/10。
- 共5例评为「满意但有学习点」,其中4例与食管异常相关,这些参与者随后诊断为食管癌。
临床应用与阅片要点
- 对阴性低剂量CT筛查扫描随机抽取5%进行盲法复审,并复审所有后续诊断肺外癌或间期肺癌的病例。
- 复审时放射科医生不知复审原因,以减少回顾性复审中的偏倚。
- 将原始报告评为「满意」「满意但有学习点」或「不满意」,以实现对临床表现的公正、建设性审计。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: As lung cancer screening is rolled-out, there is a need to develop an effective quality assurance (QA) framework around radiology reporting to ensure optimal implementation. Here, we report a structured QA process for low-dose CT (LDCT) scans performed in the Yorkshire Lung Screening Trial.
METHODS: Negative LDCT scans were single read after using computer-aided detection software. The radiology QA process included reviewing 5% of negative scans selected at random, and all cases with a subsequent diagnosis of extrapulmonary cancer or interval lung cancer not detected on the baseline scan. Radiologists were not informed of the reason for review and original radiology reports were scored as either "satisfactory", "satisfactory with learning points", or "unsatisfactory".
RESULTS: From 6650 participants undergoing LDCT screening, 208 negative scans were reviewed alongside 11 cases with subsequent extrapulmonary cancer and 10 cases with interval lung cancer. Overall, only three reports were ultimately judged "unsatisfactory", 1% of randomly selected negative scans (n = 2/208) and one interval lung cancer scan (n = 1/10). Four out of a total of five cases judged "satisfactory with learning points" were related to oesophageal abnormalities where the participant was subsequently diagnosed with oesophageal cancer.
CONCLUSION: The described process attempts to minimise bias in retrospective review of screening scans, and may represent a framework for future QA of national screening programmes.
ADVANCES IN KNOWLEDGE: This study describes a structured QA process for a lung cancer screening programme, involving blinded second-read of LDCT screening scans to ensure fair, constructive audit of clinical performance.
引用
- Upperton SEC, Bradley C, Bhartia BSK, et al. The radiology quality assurance process in the Yorkshire Lung Screening Trial, and findings from the baseline round of low dose CT screening for lung cancer. Br J Radiol. 2023. PMID: 37656217. doi:10.1259/bjr.20230126
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。